Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Ahead of the planned spin-off of its Bausch + Lomb division,Bausch Health Companies Inc. is seeking to expand its...